Cargando…
scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells
In December 2019, a novel coronavirus (SARS-CoV-2) was identified in COVID-19 patients in Wuhan, Hubei Province, China. SARS-CoV-2 shares both high sequence similarity and the use of the same cell entry receptor, angiotensin-converting enzyme 2 (ACE2), with severe acute respiratory syndrome coronavi...
Autores principales: | Wang, Zhengpin, Xu, Xiaojiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226809/ https://www.ncbi.nlm.nih.gov/pubmed/32283711 http://dx.doi.org/10.3390/cells9040920 |
Ejemplares similares
-
Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice
por: Wang, Zhengpin, et al.
Publicado: (2019) -
The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection
por: Qi, Jing, et al.
Publicado: (2021) -
ScRNA-seq and ST-seq in liver research
por: He, Jia, et al.
Publicado: (2023) -
scRNASequest: an ecosystem of scRNA-seq analysis, visualization, and publishing
por: Li, Kejie, et al.
Publicado: (2023) -
deMULTIplex2: robust sample demultiplexing for scRNA-seq
por: Zhu, Qin, et al.
Publicado: (2023)